Search

everythinglearnresearchcommunity

for

Search:↓

Current research explores hair growth drugs, while future research aims for personalized treatments.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Acne is a temporary skin imbalance during puberty that often resolves on its own.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Some patients may experience temporary total hair loss from hepatitis C treatment with PEG-interferon and ribavirin.

Some cases of tinea capitis, a fungal scalp infection, can look like scarring hair loss due to the body's immune response and the fungus itself.

A man's scalp infection, mistaken for bacterial, was actually a rare fungal infection treated successfully with antifungal medication.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

Tinea capitis can rarely cause urticarial skin reactions in children.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

Early diagnosis and treatment of nail and skin conditions can improve health and appearance.

Mesotherapy is more effective than topical spray for female hair loss treatment.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Human skin cells produce proenkephalin, which changes with environmental factors and skin diseases.

Human skin cells can create new hair follicles when transplanted into mice.

A herbal extract may help treat certain types of hair loss by reducing a specific gene's activity.

Skin healing from blisters can delay hair growth as stem cells focus on repairing skin over developing hair.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.